{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:07:05Z","timestamp":1792084025758,"version":"4.4.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008016","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:13:26Z","timestamp":1511378006000},"page":"e8016","source":"Crossref","is-referenced-by-count":31,"title":["Somatic KRAS mutation in an infant with linear nevus sebaceous syndrome associated with lymphatic malformations"],"prefix":"10.1097","volume":"96","author":[{"given":"Jiang","family":"Lihua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Shanshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Jialu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Kewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210309","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jaad.2009.04.059","article-title":"Sebaceous lesions and their associated syndromes: part II","volume":"61","author":"Eisen","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R2-1-20210309","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.jp.7210525","article-title":"Hemimegalencephaly and linear nevus sebaceous syndrome","volume":"21","author":"Herman","year":"2001","journal-title":"J Perinatol"},{"key":"R3-1-20210309","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0303-8467(98)00012-2","article-title":"The linear naevus sebaceus syndrome","volume":"100","author":"van de Warrenburg","year":"1998","journal-title":"Clin Neurol Neurosurg"},{"key":"R4-1-20210309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-5876(00)00419-5","article-title":"Inner ear malformations and hearing loss in linear nevus sebaceous syndrome","volume":"56","author":"Yu","year":"2000","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R5-1-20210309","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat Genet"},{"key":"R6-1-20210309","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum Mutat"},{"key":"R7-1-20210309","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jid.2012.379","article-title":"Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus","volume":"133","author":"Levinsohn","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R8-1-20210309","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R9-1-20210309","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12881-015-0247-1","article-title":"KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant","volume":"16","author":"Wang","year":"2015","journal-title":"BMC Med Genet"},{"key":"R10-1-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ced.12209","article-title":"Naevus sebaceus: a mosaic RASopathy","volume":"39","author":"Aslam","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"R11-1-20210309","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/01.PRS.0000046246.50517.A6","article-title":"Surgical management of the cutaneous manifestations of linear nevus sebaceus syndrome","volume":"111","author":"Margulis","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R12-1-20210309","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.41.2_Part_1.266","article-title":"Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy","volume":"41","author":"Pavone","year":"1991","journal-title":"Neurology"},{"key":"R13-1-20210309","doi-asserted-by":"crossref","first-page":"e686","DOI":"10.1111\/j.1365-2230.2009.03422.x","article-title":"Epibulbar complex choristoma and hemimegalencephaly in linear sebaceous naevus syndrome","volume":"34","author":"Park","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R14-1-20210309","first-page":"220","article-title":"Ophthalmic manifestations of linear nevus sebaceous\/organoid nevus syndrome","volume":"25","author":"Kausar","year":"2015","journal-title":"J Coll Phys Surg Pak"},{"key":"R15-1-20210309","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MOP.0000000000000209","article-title":"Management of lymphatic malformations in children","volume":"27","author":"Bagrodia","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"R16-1-20210309","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.oraloncology.2011.08.001","article-title":"Treatment guidelines of lymphatic malformations of the head and neck","volume":"47","author":"Zhou","year":"2011","journal-title":"Oral Oncol"},{"key":"R17-1-20210309","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1399-0004.1996.tb02394.x","article-title":"Discordant monozygotic twins with the Schimmelpenning-Feuerstein-Mims syndrome","volume":"50","author":"Schworm","year":"1996","journal-title":"Clin Genet"},{"key":"R18-1-20210309","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/ajmg.a.33635","article-title":"Discordance for Schimmelpenning-Feuerstein-Mims syndrome in monochorionic twins supports the concept of a postzygotic mutation","volume":"152a","author":"Rijntjes-Jacobs","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R19-1-20210309","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jmg.2009.075374","article-title":"Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma","volume":"47","author":"Bourdeaut","year":"2010","journal-title":"J Med Genet"},{"key":"R20-1-20210309","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ajmg.a.37135","article-title":"A postzygotic NRAS mutation in a patient with Schimmelpenning syndrome","volume":"167a","author":"Kuroda","year":"2015","journal-title":"Am J Med Genet A"},{"key":"R21-1-20210309","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/jid.2012.377","article-title":"Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome","volume":"133","author":"Sun","year":"2013","journal-title":"J Invest dermatol"},{"key":"R22-1-20210309","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.annder.2013.02.009","article-title":"MAP-kinase pathway activation in nevus sebaceous and Schimmelpenning syndrome","volume":"140","author":"Dereure","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"R23-1-20210309","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI71614","article-title":"Genetics of lymphatic anomalies","volume":"124","author":"Brouillard","year":"2014","journal-title":"J Clin Invest"},{"key":"R24-1-20210309","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2213-0802-1-6","article-title":"Oncogenic driver mutations in lung cancer","volume":"1","author":"Luo","year":"2013","journal-title":"Transl Respir Med"},{"key":"R25-1-20210309","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1200\/JCO.2017.35.15_suppl.2508","article-title":"First-in-class oral ERK1\/2 inhibitor Ulixertinib (BVD-523) in patients with advanced solid tumors: final results of a phase I dose escalation and expansion study","volume":"35","author":"Li","year":"2017","journal-title":"J Clin Oncol"},{"key":"R26-1-20210309","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1200\/JCO.2017.35.15_suppl.2506","article-title":"Results from the biomarker-driven basket trial of RO5126766 (CH5127566), a potent RAF\/MEK inhibitor, in RAS- or RAF-mutated malignancies including multiple myeloma","volume":"35","author":"Chenard-Poirier","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:32:38Z","timestamp":1620959558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711270-00001"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":26,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008016","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}